FREE Patient
Sample and $0 Co-pay
Discount Card
Improves each of the
key measures of
your lipid profile1
Once daily 160mg
dose, taken with
or without food1
5% rate of
discontinuation
compared to 3%
for placebo1
160mg Triglide exhibits
comparable bioavailability
to 200mg fenofibrate
capsules, micronized1
Five Reasons to Consider Triglide®
Click here to access
FREE Patient Sample and
$0 Co-Pay Discount Card
WE’VE MADE TRIGLIDE®
MORE AFFORDABLE.
FREE trial for new patients, plus unlimited refills at a $0 co-pay. Click on the card graphic (left) for immediate access to downloadable card. Some exclusions may apply.
Physicians and Pharmacists: Download cards as needed to provide to your patients. Card entitles each patient to one FREE TRIAL and unlimited refills at a $0 co-pay.
Patients: Download card for FREE TRIAL and unlimited refills at a $0 co-pay. Not valid without prescription from your physician.
Cards accepted at retail pharmacies for eligible patients with commercial insurance. Not valid for prescriptions covered under Medicaid, Medicare and other federal or state programs.
Healthcare Professionals
Triglide® is indicated as an adjunctive therapy to diet for patients with
FOR PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA1
FOR PATIENTS WITH MIXED DYSLIPIDEMIA1
FOR PATIENTS WITH SEVERE HYPERTRIGLYCERIDEMIA1
Types IV and V with baseline TG of 350 mg/dL - 499 mg/dL
Types IV and V with baseline TG of 500 mg/dL - 1500 mg/dL
HISTORY OF USE
and introduced into the US market in 19984. In 2016, over 650 million
fenofibrate doses were prescribed in the US2. Fenofibrate is cited as one
of the most commonly used fibrates worldwide and is considered generally
well-tolerated3-6.
Triglide was introduced in 2005. In double-blind, placebo-controlled trials,
200mg fenofibrate capsules (equivalent to 160mg Triglide tablets) resulted
in adverse events that led to discontinuation in 5% of patients, compared to
3% of patients treated with placebo1.
IDD®-P MICROPARTICLE TECHNOLOGY
its 160mg tablet formulation, it is the only fenofibrate that utilizes
patented IDD®-P MicroParticle technology that reduces drug particle
size and increases the total surface area of the active medication
within the tablet. Both of these factors contribute to enhanced
absorption and optimized bioavailability1.
A single 160mg Triglide tablet exhibits comparable bioavailability to
a single 200mg fenofibrate capsule, micronized1. The extent
of absorption of Triglide is comparable between fed and fasted
conditions, so it can be taken with or without food1.
CONVENIENT FOR YOUR PATIENTS
day, with or without food1.
FREE TRIAL PLUS UNLIMITED REFILLS
WITH A $0 CO-PAY
Click on the card below to download FREE Patient Sample and
$0 Co-pay Discount cards.
FOR PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA1
of 31%
of 24%
of 22%
of 10%
FOR PATIENTS WITH MIXED DYSLIPIDEMIA1
of 20%
of 36%
of 17%
of 15%
FOR PATIENTS WITH SEVERE HYPERTRIGLYCERIDEMIA1
of 46% in Frederickson Types IV
and V with baseline TG of 350 mg/dL -
499 mg/dL
of 55% in Frederickson Types IV
and V with baseline TG of 500 mg/dL -
1500 mg/dL
HISTORY OF USE
practice in France in 19753 and introduced into
the US market in 19984. In 2016, over 650
million fenofibrate doses were prescribed in the US2.
Fenofibrate is cited as one of the most
commonly used fibrates worldwide and is
considered generally well-tolerated3-6.
Triglide was introduced in 2005. In double-
blind, placebo-controlled trials, 200mg
fenofibrate capsules (equivalent to 160mg
Triglide tablets) resulted in adverse events
that led to discontinuation in 5% of patients,
compared to 3% of patients treated with
placebo1.
IDD®-P MICROPARTICLE TECHNOLOGY
equivalent. Its uncommon formulation
is based on patented IDD®-P MicroParticle
technology that reduces drug particle
size and increases the total surface area of
the active medication within the tablet. Both
of these factors contribute to enhanced
absorption and optimized bioavailability1.
Single doses of 160mg Triglide® tablets exhibit
comparable bioavailability to single doses of
200mg fenofibrate capsules, micronized1. The
extent of absorption of Triglide® (AUC) is
comparable between fed and fasted conditions.
CONVENIENT FOR YOUR PATIENTS
be taken any time of day, with or without
food.
FREE TRIAL PLUS UNLIMITED REFILLS
WITH A $0 CO-PAY
at a $0 CO-PAY. Click on the card below to download FREE Patient
Sample and $0 Co-pay Discount cards.
Click to connect with a Triglide® Sales Rep.
Get more information and answers to your questions from the convenience of your home or office.
Triglide representatives are available 5 days a week:
8am – 8pm EST, Monday through Thursday
8am – 6pm EST, Friday
Or click here to request an appointment through our automated meeting scheduler.
Patients
If you’re concerned about your cholesterol, your triglycerides, your lipid profile or the cost of your medications, you may want to speak to your doctor about Triglide®, a complete fenofibrate.